Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats

References

• BanerjeeRLiposomes: applications in medicineJ Biomater Appl200116132111475357
   PubMed Web of Science ®Google Scholar
• MamotCDrummondDCHongKKirpotinDBParkJWLiposome-based approaches to overcome anticancer drug resistanceDrug Resist Updat20036527127914643297
   PubMed Web of Science ®Google Scholar
• MoghimiSPatelHSerum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system – the concept of tissue specificityAdv Drug Deliv Rev1998321–2456010837635
   PubMed Web of Science ®Google Scholar
• ImmordinoMLDosioFCattelLStealth liposomes: review of the basic science, rationale, and clinical applications, existing and potentialInt J Nanomedicine20061329731517717971
   PubMed Web of Science ®Google Scholar
• YuanFLeunigMHuangSKBerkDAPapahadjopoulosDJainRKMicrovascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograftCancer Res19945413335233568012948
   PubMed Web of Science ®Google Scholar
• MaedaHThe enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targetingAdv Enzyme Regul200141118920711384745
   PubMedGoogle Scholar
• SuzukiSWatanabeSMasukoTHashimotoYPreparation of long-circulating immunoliposomes containing adriamycin by a novel method to coat immunoliposomes with poly(ethylene glycol)Biochim Biophys Acta1995124519167654771
   PubMed Web of Science ®Google Scholar
• MoreiraJNGasparRAllenTMTargeting stealth liposomes in a murine model of human small cell lung cancerBiochim Biophys Acta20011515216717611718672
   PubMed Web of Science ®Google Scholar
• GabizonAShmeedaHHorowitzATZalipskySTumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugatesAdv Drug Deliv Rev20045681177119215094214
   PubMed Web of Science ®Google Scholar
• DeryckeASLKamuhabwaAGijsensATransferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cellsJ Natl Cancer Inst200496211620163015523091
   PubMedGoogle Scholar
• LukyanovANElbayoumiTAChakilamARTorchilinVPTumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibodyJ Control Release2004100113514415491817
   PubMed Web of Science ®Google Scholar
• HamaguchiTMatsumuraYNakanishiYAntitumor effect of MCC-465, pegylated liposomal doxorubicin tagged with newly developed monoclonal antibody GAH, in colorectal cancer xenograftsCancer Sci200495760861315245599
   PubMed Web of Science ®Google Scholar
• HosokawaSTagawaTNikiHHirakawaYNohgaKNagaikeKEfficacy of immunoliposomes on cancer models in a cell-surface-antigen-density- dependent mannerBr J Cancer20038981545155114562030
   PubMed Web of Science ®Google Scholar
• MaruyamaKTakizawaTYudaTKennelSJHuangLIwatsuruMTargetability of novel immunoliposomes modified with amphipathic poly (ethylene glycol)s conjugated at their distal terminals to monoclonal antibodiesBiochim Biophys Acta19951234174807880861
   PubMed Web of Science ®Google Scholar
• MatsumuraYGotohMMuroKPhase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancerAnn Oncol200415351752514998859
   PubMed Web of Science ®Google Scholar
• EmsleyJKnightCGFarndaleRWBarnesMJLiddingtonRCStructural basis of collagen recognition by integrin α2β1Cell20001011475610778855
   PubMed Web of Science ®Google Scholar
• XiongJPStehleTZhangRCrystal structure of the extracellular segment of integrin alpha Vbeta 3 in complex with an Arg-Gly-Asp ligandScience2002296556515115511884718
   PubMed Web of Science ®Google Scholar
• HumphriesJDByronAHumphriesMJIntegrin ligands at a glanceJ Cell Sci2006119193901390316988024
   PubMed Web of Science ®Google Scholar
• ShimaokaMXiaoTLiuJHStructures of the αL I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulationCell200311219911112526797
   PubMed Web of Science ®Google Scholar
• KeenanRMCallahanJFSamanenJMConformational preferences in a benzodiazepine series of potent nonpeptide fibrinogen receptor antagonistsJ Med Chem199942454555910052962
   PubMed Web of Science ®Google Scholar
• FisherMJGunnBHarmsCSNon-peptide RGD surrogates which mimic a Gly-Asp β-turn: potent antagonists of platelet glycoprotein IIb-IIIaJ Med Chem19974013208521019207949
   PubMed Web of Science ®Google Scholar
• ZablockiJAMiyanoMGarlandRBPotent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp-Phe sequence of fibrinogen. A proposal on the nature of the binding interaction between the Arg-guanidine of RGDX mimetics and the platelet GP IIb-IIIa receptorJ Med Chem19933613181118198515420
   PubMed Web of Science ®Google Scholar
• EgbertsonMSChangCTCDugganMENon-peptide fibrinogen receptor antagonists. 2. Optimization of a tyrosine template as a mimic for Arg-Gly-AspJ Med Chem19943716253725518057299
   PubMed Web of Science ®Google Scholar
• ZablockiJARicoJGGarlandRBPotent in vitro and in vivo inhibitors of platelet aggregation based upon the Arg-Gly-Asp sequence of fibrinogen. (aminobenzamidino) succinyl (ABAS) series of orally active fibrinogen receptor antagonistsJ Med Chem19953813237823947608903
   PubMed Web of Science ®Google Scholar
• HutchinsonJHCookJJBrashearKMNon-peptide glycoprotein IIb/IIIa antagonists. II. Design and in vivo evaluation of 3, 4-dihydro-1 (1H)-isoquinolinone-based antagonists and ethyl ester prodrugsJ Med Chem19963923458345918917647
   PubMed Web of Science ®Google Scholar
• RuoslahtiERGD and other recognition sequences for integrinsAnnu Rev Cell Dev Biol19961216977158970741
   PubMed Web of Science ®Google Scholar
• KimCKLimSJLiposome immunoassay (LIA) with antigen-coupled liposomes containing alkaline phosphataseJ Immunol Methods19931591–21011068445242
   PubMed Web of Science ®Google Scholar
• KimCKChoiYJSoo-JeongLLeeMGLeeSHHwangSJLymph node targeting and pharmacokinetics of [3H] methotrexate-encapsulated neutral large unilamellar vesicles and immunoliposomesInt J Pharm1993981–3918
   Google Scholar
• RinkHSolid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resinTetrahedron Lett1987283337873790
   Web of Science ®Google Scholar
• BaranyGKneib-CordonierNMullenDGSolid-phase peptide synthesis: a silver anniversary reportInt J Pept Protein Res19873067057393326854
   PubMedGoogle Scholar
• HaranGCohenRBarLKBarenholzYTransmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak basesBiochim Biophys Acta1993115122012158373796
   PubMed Web of Science ®Google Scholar
• BolotinEMCohenRBarLKAmmonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomesJ Liposome Res199441455479
   Google Scholar
• UsterPSAllenTMDanielBEMendezCJNewmanMSZhuGZInsertion of poly (ethylene glycol) derivatized phospholipid into preformed liposomes results in prolonged in vivo circulation timeFEBS Lett19963862–32432468647291
   PubMed Web of Science ®Google Scholar
• NallamothuRWoodGCPattilloCBA tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluationAAPS Pharm Sci Tech200672716
   Web of Science ®Google Scholar
• ShinozawaSMimakiYArakiYOdaTDetermination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatographyJ Chromatogr198019634634697430305
   PubMed Web of Science ®Google Scholar
• VaageJMayhewELasicDMartinFTherapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomesInt J Cancer19925169429481639542
   PubMed Web of Science ®Google Scholar
• MaurerNFenskeDBCullisPRDevelopments in liposomal drug delivery systemsExpert Opin Biol Ther20011692394711728226
   PubMed Web of Science ®Google Scholar
• HansenCBKaoGYMoaseEHZalipskySAllenTMAttachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling proceduresBiochim Biophys Acta1995123921331447488618
   PubMed Web of Science ®Google Scholar
• MoreiraJNIshidaTGasparRAllenTMUse of the post-insertion technique to insert peptide ligands into pre-formed stealth liposomes with retention of binding activity and cytotoxicityPharm Res200219326526911934232
   PubMed Web of Science ®Google Scholar
• XiongXBHuangYLuWEnhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimeticJ Control Release2005107226227516125816
   PubMed Web of Science ®Google Scholar
• XiangGWuJLuYLiuZLeeRJSynthesis and evaluation of a novel ligand for folate-mediated targeting liposomesInt J Pharm20083561293618258394
   PubMed Web of Science ®Google Scholar
• IinumaHMaruyamaKOkinagaKIntracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancerInt J Cancer200299113013711948504
   PubMed Web of Science ®Google Scholar
• TurkMJWatersDJLowPSFolate-conjugated liposomes preferentially target macrophages associated with ovarian carcinomaCancer Lett2004213216517215327831
   PubMed Web of Science ®Google Scholar
• EmanuelNKedarEBolotinEMSmorodinskyNIBarenholzYTargeted delivery of doxorubicin via sterically stabilized immunoliposomes: pharmacokinetics and biodistribution in tumor-bearing micePharm Res19961368618688792423
   PubMed Web of Science ®Google Scholar